Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain.
Pneumocystis jirovecii colonisation may occur among cystic fibrosis (CF) patients because of their underlying pulmonary disease. A wide epidemiological analysis was performed among CF patients from Spain to assess the prevalence of P. jirovecii colonisation and the distribution of different genotypes. P. jirovecii was identified by nested PCR targeting the mitochondrial large-subunit rRNA gene from sputum samples or oropharyngeal washes. The genotype was determined by direct sequencing. The prevalence of P. jirovecii colonisation among 88 consecutive CF patients was 21.5%. The polymorphisms identified were 85C/248C (45.4%), 85T/248C (27.2%) and 85A/248C (18.1%); in one case, a mix of genotypes was found. Colonisation was more frequent in subjects aged < 18 years (25.5% vs. 15.1%). Among the patients studied, 20.8% received treatment with azithromycin; all of these patients were colonised with P. jirovecii, but none developed Pneumocystis pneumonia (PcP) during a 1-year follow-up period. Concordance in the colonisation status of siblings suggested a common source of infection or person-to-person transmission.
Respaldiza
N
N
Department of Internal Medicine and Cystic Fibrosis Unit, Virgen del Rocío University Hospital, Seville, Spain.
Montes-Cano
M A
MA
Dapena
F J
FJ
de la Horra
C
C
Mateos
I
I
Medrano
F J
FJ
Calderon
E
E
Varela
J M
JM
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications*; D005260:Female; D005838:Genotype; D006801:Humans; D007223:Infant; D008297:Male; D045363:Pneumocystis carinii / Q000235:genetics* / Q000254:growth & development / Q000302:isolation & purification; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000453:epidemiology* / Q000382:microbiology; D015995:Prevalence; D013030:Spain / Q000453:epidemiology